Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001797958 | SCV002041835 | likely pathogenic | Neuronal ceroid lipofuscinosis | 2021-11-10 | criteria provided, single submitter | clinical testing | Variant summary: KCTD7 c.731delT (p.Leu244ArgfsX29) results in a premature termination at codon 273, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Other variants causing premature termination at codon 273 or at a downstream codon (e.g. p.Ile199SerfsX74, p.Phe232LeufsX41, p.Trp289X) have been cited in various databases (ClinVar, HGMD, LOVD) as pathogenic and disease-associated. The variant was absent in 251276 control chromosomes (gnomAD). To our knowledge, no occurrence of c.731delT in individuals affected with Neuronal Ceroid-Lipofuscinosis (Batten Disease) and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |